Ozempic and Wegovy could double as kidney disease treatment, study suggests

Ozempic could help treat kidney disease patients, new study finds

***Watch previous Ozempic coverage above.*** (WJW) - A popular medication commonly used to treat diabetes and for weight loss can also help patients with chronic kidney disease, according to a recent study. The study, led by researchers at the University of New South Wales Sydney, found that the semaglutide drug, better known by brand names Ozempic and Wegovy, can help prevent kidney failure and death in type 2 diabetics and kidney disease patie…

Ozempic and Wegovy could double as kidney disease treatment, study suggests

Semaglutide medications including Ozempic and Wegovy have been shown to reduce kidney failure risk and the risk of death among people with kidney disease and type 2 diabetes. Two doctors weighed in.

Ozempic adds 'saving kidneys, hearts and lives' to its list of benefits

The antidiabetic and weight loss drug semaglutide (Ozempic, Wegovy) is already a worldwide smash hit, and its list of health benefits outside these uses keeps getting longer. Recent studies have found it reduced heart risks in overweight non-diabetics and could be a treatment for alcohol use disorder. Now, a new study has found even more uses for the wonder drug.Continue ReadingCategory: Medical, ScienceTags: Ozempic, Diabetes, kidney, Universit…

Ozempic Cuts Risk of Death from Kidney Disease, Major Study Finds

The active compound in the best-selling drug Ozempic markedly lowers the risk of complications from chronic kidney disease, according to a multiyear study published Friday - a finding that could dramatically expand the pool of patients eligible for the injections.

Study: Ozempic Cuts Risk Of Death By Kidney Disease - WCCB Charlotte's CW

CHARLOTTE, N.C. – New research shows that weekly injections of semaglutide medication, like Ozempic and Wegovy, cut the risk of severe outcomes from diabetic kidney disease. Overall, the risk, including kidney failure and death from kidney or cardiovascular disease, was reduced by 24%. Researchers found for those taking the weekly injections that kidney function declines more slowly compared to those getting the placebo. They also found the risk…

Ozempic cuts kidney-disease risks, research finds

Novo Nordisk’s diabetes drug Ozempic reduces the risk of kidney failure and death in patients who have both Type 2 diabetes and chronic kidney disease, according to new research published Friday.